FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia
Open Access
- 16 November 2006
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 6 (12) , 2912-2921
- https://doi.org/10.1111/j.1600-6143.2006.01552.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- FTY720/Cyclosporine Regimens in De Novo Renal Transplantation: A 1-Year Dose-Finding StudyAmerican Journal of Transplantation, 2006
- Conversion to C2 monitoring of cyclosporine A exposure in maintenance kidney transplant recipients: Results at 3 yearsAmerican Journal of Kidney Diseases, 2004
- Conversion to C2 monitoring of cyclosporine A exposure in maintenance kidney transplant recipients: Results at 3 yearsAmerican Journal of Kidney Diseases, 2004
- FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier FunctionAmerican Journal of Transplantation, 2004
- Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1Nature, 2004
- Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I studyTransplantation, 2003
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate ReceptorsJournal of Biological Chemistry, 2002
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976